EuroAPI Header EuroAPI Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Comanche Biopharma.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Comanche Biopharma
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Concord, Massachusetts
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Comanche will initiate a clinical study of CBP-4888, a fixed-dose combination of two small interfering ribonucleic acid (siRNAs) duplex oligonucleotides targeting soluble fms-like tyrosine kinase–1 (sFLT1) mRNA isoformse, in pregnant preeclamptic patients.


Lead Product(s): CBP-4888

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: CBP-4888

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Google Ventures

Deal Size: $75.0 million Upfront Cash: Undisclosed

Deal Type: Series B Financing January 17, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

CBP-4888 is a fixed-dose combination of siRNA-2283 and siRNA-2519 targeting two soluble fms-like tyrosine kinase–1 (sFLT1) mRNA isoforms, which is investigated for the treatment of sFlt-1 mediated pre-term preeclampsia.


Lead Product(s): siRNA-2283,siRNA-2519

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: CBP-4888

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 23, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

CBP-4888 is a fixed-dose combination of two chemically-synthesized, lipid-conjugated siRNAs duplex oligonucleotides (siRNA-2283 and siRNA-2519) targeting and decreasing the production of soluble fms-like tyrosine kinase-1 in the placenta, as a treament for preeclampsia.


Lead Product(s): CBP-4888

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: CBP-4888

Highest Development Status: IND EnablingProduct Type: Large molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 30, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY